PETER FRIEDLAND

Garnett Passe Rodney Williams Foundation Professorial Chair in Otolaryngology-Head and Neck Surgery

University of Western Australia

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Medical Imaging Medical Imaging professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Friedland is the Garnett Passe Rodney Williams Foundation Professorial Chair in Otolaryngology-Head and Neck Surgery at the University of Western Australia. His research focuses on various aspects of otolaryngology, including the efficacy of povidone-iodine nasal spray, cochlear implantation outcomes, and the management of otitis media in children. He has contributed to studies examining prognostic indicators in head and neck cancer and has been involved in innovative approaches to enhance surgical outcomes and patient care.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

Ruth Thornton

University of Western Australia

AUSTRALIA

View details

Dayse Tavora-Vieira

University in Western Australia

AUSTRALIA

View details

Jafri Kuthubutheen

University of Western Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

PETER FRIEDLAND

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Advanced age is not a predictor for cochlear implantation outcomes in adults with moderate to profound sensorineural hearing loss

Intraoperative Compound Action Potentials as a Predictor of Postoperative Cortical Auditory Evoked Potentials in Cochlear Implant Users

Povidone-iodine nasal spray (Nasodine®) for the common cold

Haemophilus influenzae remains the predominant otitis media pathogen in Australian children undergoing ventilation tube insertion in the PCV13 era

Prognostic impact of neutrophil-lymphocyte ratio in head and neck cancer

Phase 1 study of the iodine absorption, safety, and tolerability of a 0.5% povidone-iodine nasal spray (Nasodine)

Phase II trial of the impact 0.5% povidone-iodine nasal spray (Nasodine®) on shedding of SARS-CoV-2

Enhancing epistaxis blood loss estimation with an online visual aid

Evaluation of the Performance of OTOPLAN-Based Cochlear Implant Electrode Array Selection

In vitro Nasodine Can be an Effective Antibiofilm Agent for Biofilms that May Cause CRS

Spontaneous Intracranial Hypotension

Collaborators (3)

Ruth Thornton

Dayse Tavora-Vieira

Jafri Kuthubutheen

Make your next move.